Heidelberg

• A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece … Recruiting
  2023-504885-50-00 5 2022-11-07 Treatment of children with chronic kidney disease and proteinuria
• A Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 in Patients with Advanced NSCLC and Other Solid Tumors … Recruiting
  2024-514266-39-00 7 2022-11-03 Advanced Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors wit
• CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE … Recruiting
  2022-500764-35-00 6 2022-10-13 Patients with advanced HER2-negative, hormone receptor positive (HER2n
• A first-in-human, phase I, single-center, open-label, dose-escalation trial in healthy volunteers to assess safety, tolerability, and immuno … Recruiting
  2024-511493-67-00 1 2022-10-07 Prophylactic vaccination against HPV in healthy volunteers
• A phase IIa, randomized, placebo-controlled, double-blind, cross-over study to evaluate safety and efficacy of subcutaneous administration o … Recruiting
  2023-510376-31-00 4 2022-10-05 Cystic fibrosis
• Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or … Recruiting
  2023-507461-26-00 5 2022-09-22 Newly diagnosed acute myeloid leukemia (AML)
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia … Recruiting
  2023-510384-36-00 5 2022-09-13 Newly Diagnosed Multiple Myeloma
• Early Stage Follicular LymphOma and RadioTherapy PLUS anti-CD20 Antibody Recruiting
  2023-509278-41-00 5 2022-07-04 Early Stage Follicular LymphOma
• International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting
  2022-501180-40-00 5 2022-06-17 Ewing Sarcoma
• Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Recruiting
  2024-511201-32-00 5 2022-06-13 Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
• RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting
  2023-503267-42-00 5 2022-06-10 Patients with a histological diagnosis of mismatch- repair deficient h
• Study of the efficacy of intratumoral injections of L19IL2 + L19TNF followed by surgery to prevent or retard appearance of new metastases Recruiting
  2023-507119-36-00 5 2022-05-09 Malignant melanoma of the skin in patients with locally advanced and f
• A non blinded phase-II study with 3 randomized patient groups of individualized suppression of the patient's immune system with donor modifi … Recruiting
  2024-513446-12-00 4 2022-05-03 Living donor kidney transplantation
• Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy (MecMeth/ NOA-24) Recruiting
  2024-511264-89-00 4 2022-04-11 Glioblastoma
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo … Recruiting
  2023-508963-58-00 4 2022-01-31 Symptomatic hypertrophic cardiomyopathy (HCM)
• Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. Recruiting
  2023-505497-14-00 4 2021-12-09 Proteinuric glomerular diseases including: •Focal segmental glomerulo
• SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting
  2024-510578-25-00 5 2021-11-05 Histologically proven high-risk medulloblastoma, with any of the curre
• A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients with Plasma C … Recruiting
  2024-515273-10-00 7 2021-10-19 Relapsed or refractory Multiple Myeloma (r/r MM)
• A Phase 2 Study to Test Effects of Using DAY101 in Children with Brain Cancer Recruiting
  2024-510691-20-00 4 2021-09-23 RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced So
• Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory s … Recruiting
  2024-516392-33-00 5 2021-09-17 Patients (18-75 years) with metastatic and/or refractory soft-tissue s
• The ABC-HCC Trial: A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoemboli … Recruiting
  2024-512953-26-00 5 2021-07-06 intermediate-stage hepatocellular carcinoma
• A clinical trial investigating the safety, tolerability, and therapeutic effects of BNT113 in combination with pembrolizumab versus pembroli … Recruiting
  2024-512671-12-00 10 2021-03-05 Unresectable head and neck squamous cell carcinoma, metastatic head an
• Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal … Recruiting
  2024-515708-38-01 7 2021-01-29 Heart failure
• Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 glioma with co-deletion of 1p/19q - IMPROVE CODEL: the NOA- … Recruiting
  2024-510616-73-00 5 2020-12-16 newly diagnosed WHO grade 2 or 3 glioma

Showing 313–336 of 732 trials